Are you Dr. Brooks?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1845 W Orange Grove Rd Bldg 2
Tucson, AZ 85704Phone+1 520-531-8967Fax+1 520-742-7180
Summary
- Dr. Donald Brooks, MD is an oncologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona and Texas. He is affiliated with Northwest Medical Center, Banner - University Medical Center Tucson, and Oro Valley Hospital.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1991 - 1994
University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1988 - 1991- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1986 - 1988
University of Texas Southwestern Medical SchoolClass of 1986
Certifications & Licensure
AZ State Medical License 1992 - 2026
TX State Medical License 1987 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2012 Oct 31
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 10 citationsPhase I Clinical Trials of Tezacitabine [(E)-2′-Deoxy-2′-(fluoromethylene)cytidine] in Patients with Refractory Solid TumorsGladys Rodriguez, Richard E. Jones, Elaine K. Orenberg, Maxine L. Stoltz, Donald J. Brooks
Clinical Cancer Research. 2002-09-01 - 54 citationsExpression of the zinc finger gene EVI-1 in ovarian and other cancers.Donald J. Brooks, Suann S Woodward, FH Thompson, B. Dos Santos, M Russell
British Journal of Cancer. 1996-11-01 - 47 citationsPhase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6Donald J. Brooks, C Taylor, B. Dos Santos, Helio van der Linden, A Houghton
Clinical Cancer Research. 1995-11-01
Professional Memberships
- Member
- Member
